Promoter hypermethylation of CAVIN3, a protein that regulates activity of BRCA1, is associated with resistance to oxaliplatin in CRC cell lines in vitro and reduces progression-free survival in patients with metastatic CRC [43]. Here, CAVIN3 is linked to colorectal carcinoma.